Return to bibliography main page.

 

Bandara L.R. and Kennedy S. 2002. Toxicoproteomics—a new preclinical tool. Drug Discovery Today. 7(7):411-8.

Benninghoff A. 2007. Toxicoproteomics: the next step in the evolution of environmental biomarkers. Toxicological Sciences. 95(1):1-4.

Ge Y., et al. 2007. Toxicoproteomics and its application to human health risk assessment. Proteomics—Clinical Applications. 1(12):1613-24.

George J., et al. 2010. Toxicoproteomics: new paradigms in toxicology research. Toxicological Mechanisms & Methods. 20(7):415-423.

Hood E. 2003. Proteomics: characterizing the cogs in the machinery of life. Environmental Health Perspectives. 111(15):A816-25.

Liu J.J. and Zhuang Z.X. 2010. [Toxicoproteomics and human health risk assessment]. Zhonghua Yu Fang Yi Xue Za Zhi. 44(6):478-0. Chinese.

Merrick B.A. 2008. The role of toxicoproteomics in assessing organ specific toxicity. EXS.99:367-400.

Merrick B.A. and Tomer K.B. 2003. Toxicoproteomics: a parallel approach to identifying biomarkers. Environmental Health Perspectives.111(11):A578-9.

Spence P. 2002. Toxicoproteomics: learning to walk before it can run. Drug Discovery Today. 7(11):597.

Wetmore B.A. and Merrick B.A. 2004. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicologic Pathology. 32(6):619-42.

Yu L.R. 2011. Pharmacoproteomics and toxicoproteomics: the field of dreams. Journal of Proteomics. 74(12):2549-53.

  • No labels